Association between IL6 gene variants -174G>C and -572G>C and serum IL-6 levels: Interactions with social position in the Whitehall II cohort

Atherosclerosis

Volumn 204, Issue 2, 2009, Pages 459-464

  Sanderson, Saskia C ^a,b,c   Kumari, Meena ^a   Brunner, Eric J ^a   Miller, Michelle A ^d   Rumley, Ann ^e   Lowe, Gordon D ^e   Marmot, Michael G ^a   Humphries, Steve E ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Epidemiology; Genes; Genetics; Inflammation; Interleukins

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; COHORT STUDIES; EMPLOYMENT; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-6; LINEAR MODELS; LONDON; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SOCIAL CLASS; SOCIAL ENVIRONMENT; TIME FACTORS;

EID: 67349113938     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.09.019     Document Type: Article

References (32)

1. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 8 Suppl. 2 (2006) S3
2. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214
3. Danesh J., Kaptoge S., Mann A.G., et al. Long term interleukin-6 levels and subsequent risk of coronary heart disease: two prospective studies and a systematic review. PLoS Med 5 (2008) E78
4. Mohamed-Ali V., Goodrick S., Rawesh A., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82 (1997) 4196-4200
5. Herder C., Schneitler S., Rathmann W., et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 92 (2007) 4569-4574
6. Kristiansen O.P., and Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent?. Diabetes 54 Suppl. 2 (2005) S114-S124
7. Gimeno D., Brunner E.J., Lowe G.D., et al. Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study. Eur J Epidemiol 22 (2007) 675-683
8. Hemingway H., Shipley M., Mullen M.J., et al. Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study). Am J Cardiol 92 (2003) 984-987
9. Worns M.A., Victor A., Galle P.R., and Hohler T. Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels-a study in twins. Genes Immun 7 (2006) 600-605
10. Wannamethee S.G., Whincup P.H., Rumley A., and Lowe G.D. Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men. J Thromb Haemost 5 (2007) 1637-1643
11. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
12. Kelberman D., Hawe E., Luong L.A., et al. Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost 92 (2004) 1122-1128
13. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275 (2000) 18138-18144
14. Brull D.J., Montgomery H.E., Sanders J., et al. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21 (2001) 1458-1463
15. Jenny N.S., Tracy R.P., Ogg M.S., et al. In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 22 (2002) 2066-2071
16. Jones K.G., Brull D.J., Brown L.C., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103 (2001) 2260-2265
17. Barbieri M., Rizzo M.R., Papa M., et al. Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factors. Exp Gerontol 40 (2005) 599-604
18. Basso F., Lowe G.D., Rumley A., McMahon A.D., and Humphries S.E. Interleukin-6 -174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol 22 (2002) 599-604
19. Bennet A.M., Prince J.A., Fei G.Z., et al. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 171 (2003) 359-367
20. Lieb W., Pavlik R., Erdmann J., et al. No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol 97 (2004) 205-212
21. Nauck M., Winkelmann B.R., Hoffmann M.M., et al. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med 80 (2002) 507-513
22. Vickers M.A., Green F.R., Terry C., et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 53 (2002) 1029-1034
23. Ferrari S.L., Ahn-Luong L., Garnero P., Humphries S.E., and Greenspan S.L. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 88 (2003) 255-259
24. Marmot M., and Brunner E. Cohort profile: the Whitehall II study. Int J Epidemiol 34 (2005) 251-256
25. Cardellini M., Perego L., D'Adamo M., et al. C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care 28 (2005) 2007-2012
26. Smith A.J.P., D'Aiuto F., Palmen J., Cooper J.A., Samuel J., Thompson S., et al. Serum levels of interleukin-6 (IL-6) are associated with a functional IL6-6331T > C polymorphism. Clin Chem 54 (2008) 841-850
27. Samuel J.M., Kelberman D., Smith A.J.P., Humphries S.E., and Woo P.P. Identification of a novel regulatory region in the interleukin-6 gene promoter. Cytokine 42 (2008) 256-264
28. Kilpinen S., Hulkkonen J., Wang X.Y., and Hurme M. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. Eur Cytokine Netw 12 (2001) 62-68
29. Moffitt T.E., Caspi A., and Rutter M. Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry 62 (2005) 473-481
30. Talmud P.J. Gene-environment interaction and its impact on coronary heart disease risk. Nutr Metab Cardiovasc Dis 17 (2007) 148-152
31. Yang Q., and Khoury M.J. Evolving methods in genetic epidemiology. III. Gene-environment interaction in epidemiologic research. Epidemiol Rev 19 (1997) 33-43
32. Cole S.W., Hawkley L.C., Arevalo J.M., Sung C.Y., Rose R.M., and Cacioppo J.T. Social regulation of gene expression in human leukocytes. Genome Biol 8 (2007) R189